Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Current Assets (2016 - 2025)

Aethlon Medical filings provide 15 years of Current Assets readings, the most recent being $5.9 million for Q1 2025.

  • On a quarterly basis, Current Assets fell 4.43% to $5.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was $5.9 million, a 4.43% decrease, with the full-year FY2025 number at $5.9 million, down 4.43% from a year prior.
  • Current Assets hit $5.9 million in Q1 2025 for Aethlon Medical, up from $5.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $25.5 million in Q2 2021 to a low of $5.0 million in Q4 2024.
  • Median Current Assets over the past 5 years was $13.3 million (2023), compared with a mean of $13.8 million.
  • Biggest five-year swings in Current Assets: skyrocketed 75.4% in 2022 and later tumbled 58.74% in 2024.
  • Aethlon Medical's Current Assets stood at $21.2 million in 2021, then fell by 14.32% to $18.2 million in 2022, then plummeted by 54.6% to $8.2 million in 2023, then tumbled by 39.77% to $5.0 million in 2024, then grew by 19.75% to $5.9 million in 2025.
  • The last three reported values for Current Assets were $5.9 million (Q1 2025), $5.0 million (Q4 2024), and $7.1 million (Q3 2024) per Business Quant data.